CLEVELAND, Ohio — A deal with a prominent Irish medical school will broaden the Cleveland Clinic’s opportunities in Ireland and in the rest of Europe, according to a release from the university.
The Clinic agreed on Wednesday to work with the Royal College of Surgeons in Ireland to focus on medical devices and areas including orthopedics, cardiovascular disease and general surgery. The Clinic will partner with the school on clinical trials for approval in Europe and in the United States through the Food and Drug Administration.
Cleveland Clinic Innovations Director Chris Coburn called the school “the old pros in navigating an international system” with a global reach that will benefit the Clinic, according to The Plain Dealer. The Royal College has several research projects focusing on bone development, and on cardiovascular and cancer research, among other areas.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
“It provides a great opportunity for both organizations to work together to address complex health-care challenges and develop innovative medical solutions that will ultimately improve patient outcomes and reduce health-care costs,” Frank Ryan, chief executive officer of Enterprise Ireland, stated in the university release.
